Cargando…

Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer

BACKGROUND & AIMS: Although hepatocellular cancers (HCC) frequently arise in the setting of fibrosis and a hepatic regenerative response requiring new cell growth, therapeutic strategies for these cancers have not targeted protein synthesis. Silvestrol, a rocaglate isolated from Aglaia foveolata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kogure, Takayuki, Kinghorn, A. Douglas, Yan, Irene, Bolon, Brad, Lucas, David M., Grever, Michael R., Patel, Tushar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784426/ https://www.ncbi.nlm.nih.gov/pubmed/24086701 http://dx.doi.org/10.1371/journal.pone.0076136

Ejemplares similares

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease
por: Patton, John T., et al.
Publicado: (2014)

Silvestrol induces early autophagy and apoptosis in human melanoma cells
por: Chen, Wei-Lun, et al.
Publicado: (2016)

Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2013)

Inhibition of Zika Virus Replication by Silvestrol
por: Elgner, Fabian, et al.
Publicado: (2018)

Silvestrol Inhibits Chikungunya Virus Replication
por: Henss, Lisa, et al.
Publicado: (2018)

Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
por: Cencic, Regina, et al.
Publicado: (2009)

Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol
por: Glitscher, Mirco, et al.
Publicado: (2018)

Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
por: Müller, Christin, et al.
Publicado: (2018)

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer()
por: Takahashi, Kenji, et al.
Publicado: (2014)

In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol
por: Schiffmann, Susanne, et al.
Publicado: (2022)

The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapy
por: Webb, Thomas E., et al.
Publicado: (2020)

Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
por: Müller, Christin, et al.
Publicado: (2020)

Natural antiviral compound silvestrol modulates human monocyte‐derived macrophages and dendritic cells
por: Blum, Leonard, et al.
Publicado: (2020)

The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
por: Todt, Daniel, et al.
Publicado: (2018)

Inhibition of nasopharyngeal carcinoma cell proliferation and synergism of cisplatin with silvestrol and episilvestrol isolated from Aglaia stellatopilosa
por: DAKER, MAELINDA, et al.
Publicado: (2016)

In silico study on the Hepatitis E virus RNA Helicase and its inhibition by silvestrol, rocaglamide and other flavagline compounds
por: Pedroni, Lorenzo, et al.
Publicado: (2022)

The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway
por: Zhang, Wei, et al.
Publicado: (2022)

Hepatic miR-29ab1 expression modulates chronic hepatic injury
por: Kogure, Takayuki, et al.
Publicado: (2012)

Extracellular Vesicle‐Based Therapeutic Targeting of β‐Catenin to Modulate Anticancer Immune Responses in Hepatocellular Cancer
por: Matsuda, Akiko, et al.
Publicado: (2019)

Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma
por: Braconi, Chiara, et al.
Publicado: (2010)

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
por: Tsui, Yu-Man, et al.
Publicado: (2020)

Circulating extracellular vesicle‐encapsulated HULC is a potential biomarker for human pancreatic cancer
por: Takahashi, Kenji, et al.
Publicado: (2019)

Development of a Lyophilized Off-the-Shelf Mesenchymal Stem Cell-Derived Acellular Therapeutic
por: Driscoll, Julia, et al.
Publicado: (2022)

Targeting Liver Cancer Stem Cells Using Engineered Biological Nanoparticles for the Treatment of Hepatocellular Cancer
por: Ishiguro, Kaori, et al.
Publicado: (2020)

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials
por: Kogure, Akiko, et al.
Publicado: (2020)

Novel extracellular RNA biomarkers for early stage hepatocellular cancer
por: Gondaliya, Piyush, et al.
Publicado: (2021)

Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
por: Ettlin, Robert A., et al.
Publicado: (2009)

Strategies in Translating the Therapeutic Potentials of Host Defense Peptides
por: Ting, Darren Shu Jeng, et al.
Publicado: (2020)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells
por: Cardiff, Robert D, et al.
Publicado: (2011)

Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma
por: Wen, Hui-Ju, et al.
Publicado: (2018)

Translational Regulation in Hepatocellular Carcinogenesis
por: Bracic Tomazic, Suzana, et al.
Publicado: (2021)

Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma
por: Kimura, Osamu, et al.
Publicado: (2014)

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018)

Editorial: The Translational and Therapeutic Potential of the Tumor Microenvironment in Oral Cancer
por: Hunter, Keith D., et al.
Publicado: (2021)

Post-Translational Modifications of STING: A Potential Therapeutic Target
por: Kang, Jiaqi, et al.
Publicado: (2022)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

Potential Therapeutic Value of the STING Inhibitors
por: Zhang, Shangran, et al.
Publicado: (2023)

Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke
por: Lee, Jin Hwan, et al.
Publicado: (2017)

Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential
por: Marina, Digregorio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cecg772japrlp2vc5dv9833n80